NCT04677829View on ClinicalTrials.gov

Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)

PHASE1TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

April 12, 2021

Study Completion Date

April 12, 2021

Conditions
Traumatic Brain Injury
Interventions
BIOLOGICAL

PNT001

30 minute infusion for PNT001 1000mg; 60 minute infusion for PNT001 4000mg

BIOLOGICAL

%5 dextrose for infusion

30 min placebo infusion for 1000mg; 60 minute placebo infusion for 4000mg

Trial Locations (1)

19104

Penn Presbyterian Medical Center, Philadelphia

Sponsors
All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Pinteon Therapeutics, Inc

INDUSTRY